143 related articles for article (PubMed ID: 18758642)
21. Tumor karyotype predicts clinical outcome in colorectal cancer patients.
Bardi G; Fenger C; Johansson B; Mitelman F; Heim S
J Clin Oncol; 2004 Jul; 22(13):2623-34. PubMed ID: 15226330
[TBL] [Abstract][Full Text] [Related]
22. The impact of tumor location on the histopathologic expression of colorectal cancer.
Papagiorgis P; Oikonomakis I; Karapanagiotou I; Wexner SD; Nikiteas N
J BUON; 2006; 11(3):317-21. PubMed ID: 17309156
[TBL] [Abstract][Full Text] [Related]
23. [A prognostic audit in colorectal cancer: between the clinical realities and the therapeutic principles].
Diaconescu MR; Vexler L; Costea I; Brănişteanu I; Glod M
Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):174-8. PubMed ID: 10756750
[TBL] [Abstract][Full Text] [Related]
24. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.
Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T
Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744
[TBL] [Abstract][Full Text] [Related]
25. Histological grading of colorectal cancer: a simple and objective method.
Ueno H; Mochizuki H; Hashiguchi Y; Ishiguro M; Kajiwara Y; Sato T; Shimazaki H; Hase K; Talbot IC
Ann Surg; 2008 May; 247(5):811-8. PubMed ID: 18438118
[TBL] [Abstract][Full Text] [Related]
26. Correlation between family history of colorectal cancer and pathological and clinical features of the disease.
Aste H; Picasso M; Allegretti A; Conio M
Cancer Detect Prev; 1994; 18(5):343-8. PubMed ID: 7812980
[TBL] [Abstract][Full Text] [Related]
27. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
28. Comparison of outcome of open and laparoscopic resection for stage II and stage III rectal cancer.
Law WL; Poon JT; Fan JK; Lo SH
Ann Surg Oncol; 2009 Jun; 16(6):1488-93. PubMed ID: 19290491
[TBL] [Abstract][Full Text] [Related]
29. Histological grade predicts survival time associated with recurrence after resection for colorectal cancer.
Cho YB; Chun HK; Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2009; 56(94-95):1335-40. PubMed ID: 19950787
[TBL] [Abstract][Full Text] [Related]
30. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
31. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
32. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
33. [Colorectal cancer in Madagascar. A study of 81 cases diagnosed and treated at the Antananarivo General Hospital].
Pignon T; Andriamanday V; Ralantoarimihanta M; Rakotobe A; Randrianonimandimby J
Bull Cancer; 1988; 75(10):963-9. PubMed ID: 3219423
[TBL] [Abstract][Full Text] [Related]
34. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A
Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467
[TBL] [Abstract][Full Text] [Related]
35. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis?
Sarpel U; Bonavia AS; Grucela A; Roayaie S; Schwartz ME; Labow DM
Ann Surg Oncol; 2009 Feb; 16(2):379-84. PubMed ID: 19020941
[TBL] [Abstract][Full Text] [Related]
36. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
37. Loco-regional advanced colorectal cancer: diagnostic and therapeutic features.
Vîlcea ID; Vasile I; Tomescu P; Pasalega M; Meşină C; Calotă F; Mihaela C; Georgescu E; Ionescu M; Mirea C; Traşcă E; Tenea T; Mogoanta S
Chirurgia (Bucur); 2008; 103(2):189-94. PubMed ID: 18457097
[TBL] [Abstract][Full Text] [Related]
38. Analysis of prognostic factors in colorectal carcinoma.
Deliu IC; Georgescu EF; Bezna MC
Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):808-16. PubMed ID: 25341305
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic clinical and anatomopathological factors in surgery of carcinoma of the right colon].
Erba M; Boneschi M; Eusebio D; Giuffrida GF
Minerva Chir; 1997 Jun; 52(6):727-33. PubMed ID: 9324654
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic analysis of middle and lower rectal cancer with different degrees of infiltration in mesorectum].
Zhuo HQ; Zhou YB; Lü L; Zhou J; Yang WY; Li YJ
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):820-2. PubMed ID: 19595121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
